PERSONALIZED TESTING
MORE SPECIFIC DIAGNOSES, MORE PRECISE TREATMENTS
Mlabs has distinguished itself as a leader in molecular oncology by the breadth of tests we offer, the volume of tests we perform and the clarity and personalization of the consultations we provide. Let us help you choose the right test for your patient from our catalog of single gene assays and multi-gene panels.
single gene assays for breast, esophageal, bladder and biliary cancers and bone marrow transplant engraftment analysis
multiple gene test panels for colorectal cancer, non-small cell lung cancer, melanoma, gastrointestinal stromal tumor, glioma, sarcoma, AML, MPN, and lymphoma
COMPREHENSIVE TESTING SOLUTIONS
DISEASE-SPECIFIC TESTING MENU
MYELOID NEOPLASMS (AML, MDS, MPN)
NPM1 Mutation (PCR)
FLT3 Mutation (PCR)
CEBPA Mutation (Sanger)
IDH1 and IDH2 Mutation (Sanger)
KIT D816V Mutation (PCR)
KIT Mutation for AML - Exons 8, 17 (Sanger)
PML/RARA t(15;17) Translocation Qualitative (PCR)
JAK2 V617F Mutation (PCR)
JAK2 Exon 12 Mutation (PCR)
CALR Mutation (PCR)
MPL Mutation (PCR)
BCR/ABL1 Analysis, Quantitative (PCR)
BCR/ABL1 Kinase Domain Mutation (Sanger)
Myeloid NGS Panel
BREAST CANCER
LYMPHOPROLIFERATIVE DISORDERS
B Cell Clonality (PCR) (IGK & IGH Gene Rearrangement)
B Cell Clonality (PCR) (IGK Gene Rearrangement)
B Cell Clonality (PCR) (IGH Gene Rearrangement)
T Cell Clonality (PCR) (TRG & TRB Gene Rearrangement)
T Cell Clonality (PCR) (TRG Gene Rearrangement)
T Cell Clonality (PCR) (TRB Gene Rearrangement)
IGH/BCL2 t(14;18) Translocation (PCR)
IGH/BCL2 t(14;18) Translocation (FISH)
BCL6 (3q27) Rearrangement (FISH)
MYC (8q24) Rearrangement (FISH)
MALT1 (18q21) Rearrangement (FISH)
MYD88 (L265P) Mutation (PCR)
BRAF V600E/V600K Mutations (PCR)
COLORECTAL AND ENDOMETRIAL CANCER
GASTROINTESTINAL STROMAL TUMOR
GENITOURINARY TUMOR
LUNG CANCER
MELANOMA
SARCOMA
SYT/SSX Translocation (PCR)
PAX/FOXO1 Translocation (PCR)
EWSR1/WT1 Translocation (PCR)
EWSR1/ATF1 Translocation (PCR)
EWSR1/FLI1 & EWSR1/ERG Translocation (PCR)
EWSR1 (22q12) Rearrangement (FISH)
MDM2 Amplification (FISH)
CIC (19q13) Rearrangement (FISH)
DDIT3 (12Q13) Rearrangement (FISH)
PDGFB (22Q13) Rearrangement (FISH)
THYROID CANCER
INPUT REQUIREMENTS
LESS TISSUE, MORE RESULTS
LOW QNS RATE
MOLECULAR NGS PANELS WITH SPECIAL PROCESSES
We tackle critical concerns – small biopsies and miniscule aspirates submitted for targeted NGS molecular testing. Our specialized procedures produce results with less than a 3 percent QNS failure rate.
CLINICALLY ACTIONABLE INFORMATION
We identify all molecular alterations that cause individual cancers. Our NGS panel will test only for genes that have available therapy, eliminating delays and the need for more tissue.
BETTER QUALITY, PRECISE RESULTS
Every specimen is taken to its full capacity. We produce detailed and exhaustive results surpassing those of other labs. Our quality control metrics ensure accurate reports and prevent false negatives if insufficient nucleic acid hampers variant detection.
GET STARTED
Order a test today.
QUESTIONS?
WE'VE GOT ANSWERS.
- How do I order a test?
- What are acceptable samples?
- Where do I find results?
- How can I order a specimen kit?
MEET DR. BETZ
EXPERTISE DELIVERED PERSONALLY
Next generation sequencing has revolutionized pathology. Now we can use one test to measure all mutations at once while preserving the specimen. This is especially important in cancer, where fine needle tissue biopsies may contain 100 or fewer tumor cells – making them too small to conduct numerous separate assays.
Bryan Betz, Ph.D.
Associate Professor of Pathology
Technical Director, Molecular Diagnostics Laboratory
